The aims of this study are to translate our findings in mouse models to patients and determine whether variations in complement regulatory proteins leading to impaired function are associated with preeclampsia in patients with SLE and/or APL Ab and whether such variants are also present in women who develop preeclampsia in the absence of autoimmune disease. Here, FASLG is linked to preeclampsia.